Variables

Patients

GSTP1 methylation

CDH1 methylation

(n)

(%)

M

U

M

U

n (%)

n (%)

n (%)

n (%)

Totally: 80 patients

66 (82)

14 (18)

76 (95)

4 (5)

Age

≤50

19

(24)

15 (42.1)

4

17 (89.5)

2

>50

61

(76)

51 (19.7)

10

59 (88.5)

2

Stage

II

30

(37.5)

25 (38)

5

28 (37)

2

III

44

(55)

37 (56)

7

42 (55)

2

IV

6

(7.5)

4 (6)

2

6 (8)

0

Type of Tumor

IDC

67

(83.75)

58 (86.5)

9(13.5)

64 (95.5)

3(4.5)

ILC

13

(16.25)

8 (61.5)

5(38.5)

12 (92.3)

1(7.7)

Lymph Node

Positive

68

(85)

57 (86.4)

11

65(85.5)

3

Negative

12

(15)

9 (13.6)

3

11(14.5)

1

Estrogen Receptor

Positive

54

(67.5)

44 (66.7)

10

51 (67.1)

3

Negative

26

(32.5)

22 (33.3)

4

25 (32.9)

1

Progesterone Receptor

Positive

42

(52.5)

33 (50)

9

39 (51)

3

Negative

38

(47.5)

33 (50)

5

37 (49)

1

HER2/NEU

Positive

30

(37.5)

26 (39.4)

4

29 (38.2)

1

Negative

50

(62.5)

40 (60.6)

10

47 (61.8)

3